Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 1999

View Archived Issues

Dietary omega-3 fatty acids have mild effect on coronary atherosclerosis

Fujisawa updates R&D activities for FY 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

Ribonucleoside reductase inhibitors with anti-HIV activity in development at Molecules for Health

Proteus and Therapeutic Antibodies propose merger

NeuroSearch-Meiji Seika team discovers positive modulators of GABA-A receptor complex

New MMP/TNF production inhibitors presented by DuPont

Ortho-McNeil describes new dipyridoimidazole series of GABA-A receptor ligands

Immunosuppressive and antifungal sphingosine derivatives from Takara Shuzo

Yoshitomi discloses new antipsychotics in recent patent literature

News from DDW: rhIL-11 has potential in the treatment of pancreatitis

Improved PDE4 inhibitors in development at Merck Frosst

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

Japanese herbal medicine improves symptoms of nonulcer dyspepsia

Electrophysiological assessment of the sodium channel-blocking activity of RSD-921

ViroPharma to advance new anti-RSV candidate to clinical trials

Systematic review of published studies questions efficacy of carbamazepine in cocaine dependency

Avigen cleared to begin human trials of gene therapy product for hemophilia

New series with potential in HCV disease advances through the ViroPharma pipeline

NeoPharm outlines developments during the first quarter

M-100907: a potential treatment for coexisting cocaine dependence and schizophrenia

SmithKline Beecham launches antidiarrheal drug in the Philippines

Fluvoxamine maleate launched in Japan for social anxiety disorder

Humanized antibody-cytokine fusion protein demonstrates immunological activity in phase I trial

CPMP adopts positive opinion on Synagis for RSV prevention

Flavonoid derivative DA-6034 is active in animal models of IBD

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

News from APA: bupropion SR suggested to hold promise as an antiobesity treatment

Avandia receives FDA approval for treatment of type II diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...